# OnCo record nct05682443 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05682443/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05682443", "NCT05682443" ;
  schema:name "ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC"@en ;
  schema:alternateName "PRESERVE-006"@en ;
  schema:description "A phase 1/2 trial of Gotistobart, Lutetium-177 vipivotide tetraxetan in prostate cancer, run by OncoC4, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05682443/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05682443> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-12-11" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:drugs <https://onco.cc/drugs/gotistobart/>, <https://onco.cc/drugs/pluvicto/> ;
  onco:companies <https://onco.cc/companies/oncoc4/> .